Glucon Medical

Glucon Medical was a private diabetes technology company focused on noninvasive continuous glucose monitoring. Its lead product, Aprise, was a device intended to continuously track blood glucose using photoacoustic and ultrasound-based sensing approaches rather than implanted or finger-stick sampling. The company appears to have operated through an Israeli entity, Glucon Medical Ltd, and a U.S. entity, Glucon Medical, Inc., later referenced in patent assignment records as Glucon Inc. Published clinical literature and historical company materials indicate the firm ran clinical studies of Aprise in people with diabetes, but there is no clear evidence of commercialization or an active current operating business. Available secondary sources now describe the company as dissolved, suggesting it is no longer active.